Efficacy of Haritaki Churna in Prediabetes
Phase 3
- Conditions
- Health Condition 1: R730- Abnormal glucose
- Registration Number
- CTRI/2024/04/065878
- Lead Sponsor
- Dr Patil Shraddha Anilrao
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Individuals of HbA1c level between 5.7 to 6.4%
Exclusion Criteria
1.Prediabetes with other systemic conditions like thyroid dysfunction, uncontrolled hypertension with or without medication (more than or equal to 140/90 mmHg).
2.Pregnant and lactating women.
3.Individuals on medication for longer period like glucocorticosteroids, thyroid hormones, pentamidine, nicotinic acid, antipsychotics, thiazides, ß-adrenergic agonists.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method changes in Levels of HbA1c, FBS PPBSTimepoint: subjective parameters will be assessed on <br/ ><br>baseline on 0th 30th 60th 90th, day of the intervention.
- Secondary Outcome Measures
Name Time Method Improvement in QOLTimepoint: subjective parameters will be assessed on <br/ ><br>baseline on 0th 30th 60th 90th, day of the intervention.